Amir Reza Aref
Harvard University
H-index: 43
North America-United States
Top articles of Amir Reza Aref
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response | Nasim Ebrahimi Mahdokht Sadat Manavi Ferdos Faghihkhorasani Siavash Seifollahy Fakhr Fatemeh Jafari Baei | 2024/1/16 | |
Peptide-functionalized,-assembled and-loaded nanoparticles in cancer therapy | Jingyuan Dai Milad Ashrafizadeh Amir Reza Aref Gautam Sethi Yavuz Nuri Ertas | 2024/4/16 | |
Nanomaterials affecting cellular metabolism: opportunities and challenges for cancer therapy | Sepand Tehrani Fateh Sahand Tehrani Fateh Amir Salehi-Najafabadi Amir Reza Aref | 2024/1/1 | |
Natural product/diet-based regulation of macrophage polarization: Implications in treatment of inflammatory-related diseases and cancer | Milad Ashrafizadeh Amir Reza Aref Gautam Sethi Yavuz Nuri Ertas Lu Wang | 2024/4/10 | |
Commercial and regulatory challenges in cancer nanomedicine | Sepand Tehrani Fateh Sahand Tehrani Fateh Amir Salehi-Najafabadi Amir Reza Aref | 2024/1/1 | |
Abstract LB218: Advanced ex vivo platform for drug response analysis: Evaluating the potent effects of NMC-521 mAb on mouse-and patient-derived organotypic tumor spheroids | Cancer Research | Amir Aref Alyssa Martin Hamidreza Aboulkheyr Es Patryk Krzesaj Victor Adler | 2024/4/5 |
Cancer nanotechnology: a new approach to upgrade cancer diagnosis and therapy | Dorsa Morshedi Rad Hojjatollah Nazari Vahid Yaghoubi Naei Malihe Lotfi Amir Reza Aref | 2024/1/1 | |
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy | Qiang Lu Dongquan Kou Shenghan Lou Milad Ashrafizadeh Amir Reza Aref | 2024/4/2 | |
Protein corona: challenges and opportunities for cancer therapy | Sahand Tehrani Fateh Fatemeh Mehryab Sepand Tehrani Fateh Amir Salehi-Najafabadi Amir Reza Aref | 2024/1/1 | |
Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics | Cancer Letters | Yang Yang Lixia Liu Yu Tian Miaomiao Gu Yanan Wang | 2024/2/15 |
Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy | Nasim Ebrahimi Al-Hasnawi Rasool Riyadh Abdulwahid Atena Mansouri Nasrin Karimi Rashid Jafardoust Bostani | 2024/12 | |
Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology | Nasim Ebrahimi Mahdokht Sadat Manavi Ahmad Nazari Amirali Momayezi Ferdos Faghihkhorasani | 2023/10/4 | |
Exosomal miRNAs in cancer progression and diagnosis | Mehrdad Hashemi Afshin Taheriazam Sepideh Mirzaei Shokooh Salimimoghadam Amir Reza Aref | 2023 | |
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools | Akbar Hasanzadeh Arefeh Ebadati Lida Dastanpour Amir R Aref Parham Sahandi Zangabad | 2023/11/14 | |
Hypoxia inducible factor-1α (HIF-1α) in breast cancer: The crosstalk with oncogenic and onco-suppressor factors in regulation of cancer hallmarks | Sepideh Mirzaei Bijan Ranjbar Saeed Hesami Tackallou Amir Reza Aref | 2023/7/7 | |
CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer | Shiva Shirani-Bidabadi Aliye Tabatabaee Nazita Tavazohi Amirali Hariri Amir Reza Aref | 2023/6/1 | |
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions | Mehrdokht Sadrkhanloo Mahshid Deldar Abad Paskeh Mehrdad Hashemi Rasoul Raesi Motahhar Motahhary | 2023/2/1 | |
Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future | Neda Minaei Roya Ramezankhani Atena Tamimi Abbas Piryaei Ali Zarrabi | 2023/3/1 | |
Multifunctional and theranostic hydrogels for wound healing acceleration: An emphasis on diabetic-related chronic wounds | Pooya M Tehrany Parham Rahmanian Aryan Rezaee Golnaz Ranjbarpazuki Farima Sohrabi Fard | 2023/9/15 | |
Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response | Mehrdad Hashemi Pouria Daneii Mohammad Arad Zandieh Rasoul Raesi Neda Zahmatkesh | 2023/11/13 |
Co-Authors
